Soley Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-05-2024
- Paid Up Capital ₹ 0.10 M
as on 29-05-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 19.78%
(FY 2020)
- Profit -16254.44%
(FY 2020)
- Ebitda -118.00%
(FY 2020)
- Net Worth -99.35%
(FY 2020)
- Total Assets -12.03%
(FY 2020)
About Soley Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Faizan Razzaque, Rehan Khan, and Sohail Khan serve as directors at the Company.
- CIN/LLPIN
U24239MH2018PTC314218
- Company No.
314218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Soley Pharmaceutical Private Limited offer?
Soley Pharmaceutical Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Respiratory System Drugs, Anti Asthma Drug, Fitness Supplements, Ayurvedic,Herbal Products & Medicine, Ayurvedic Joint Pain Relief Capsule Tablet, Common Disease Medicines, Pharmaceutical Syrup, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Soley Pharmaceutical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Faizan Razzaque  | Director | 29-Nov-2021 | Current |
| Rehan Khan | Director | 29-Nov-2021 | Current |
| Sohail Khan | Director | 29-Nov-2021 | Current |
Financial Performance of Soley Pharmaceutical.
Soley Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.78% increase. The company also saw a substantial fall in profitability, with a 16254.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soley Pharmaceutical?
Unlock access to Soley Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Spectta Infoservices Private LimitedActive 5 years 7 monthsRehan Khan and Sohail Khan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Soley Pharmaceutical?
Unlock and access historical data on people associated with Soley Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soley Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soley Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
